Cargando…
A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of (11)C- and (14)C-labelled verapamil in healthy volunteers
Autores principales: | Wagner, Claudia C, Simpson, Marie, Lappin, Graham, Karch, Rudolf, Abrahim, Aiman, Feurstein, Thomas, Bauer, Martin, Zeitlinger, Markus, Kletter, Kurt, Müller, Markus, Langer, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313240/ http://dx.doi.org/10.1186/1471-2210-8-S1-A49 |
Ejemplares similares
-
Decreased blood-brain barrier P-glycoprotein function with aging
por: Bauer, Martin, et al.
Publicado: (2008) -
Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study
por: Bauer, Martin, et al.
Publicado: (2015) -
A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012) -
Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET
por: Bauer, Martin, et al.
Publicado: (2010) -
Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood–brain barriers studied with (R)-[(11)C]verapamil positron emission tomography
por: Müllauer, Julia, et al.
Publicado: (2012)